Companies 0 See All
Hedge Funds 0 See All
Insiders 0 See All
Institutional Investors 0 See All
Click here to see all results for
Home > Insider Trading > Inhibikase Therapeutics Inc.

Inhibikase Therapeutics Inc. (IKT)

Market is closed
Latest 13D & 13G Filings
Company Symbol Filed By Filing Date Filing
Inhibikase Therapeutics Inc.
IKT
ADAR1 Capital Management
 2026-02-17
13G Filing
Inhibikase Therapeutics Inc.
IKT
 Fairmount Funds Management LLC 2026-02-17
13G Filing
Inhibikase Therapeutics Inc.
IKT
Perceptive Advisors
 2026-02-17
13G Filing
Inhibikase Therapeutics Inc.
IKT
Nantahala Capital Management
 2026-02-13
13G Filing
Inhibikase Therapeutics Inc.
IKT
 Sands Capital Life Sciences Pulse Fund II, L.P. 2026-02-13
13G Filing
Insider Monkey Quarterly Strategy
+498.7% Insider Monkey Quarterly Strategy
+195% Benchmark50% S&P 500 ETF and 50% Russell 2000 ETF
400%
200%
0%

Returns since its inception in May 2014 (through February 18th, 2026)

Subscribe Now

30 day money back guarantee. Cancel anytime.